1. (1) As used in this section:

   1. (a) "340B covered entity" means the same as the term "covered entity" is defined in 42 U.S.C. Sec. 256b(a)(4).
   2. (b) "340B eligible drug" means a drug purchased through the 340B drug discount program, in accordance with 42 U.S.C. Sec. 256b, by a 340B covered entity.
   3. (c) "Contracted pharmacy" means a pharmacy contracting with a 340B covered entity to dispense 340B eligible drugs.
   4. (d) "Manufacturer" means a pharmaceutical manufacturer, including an agent or affiliate of a pharmaceutical manufacturer.
   5. (e) "Pharmacy" means any place where drugs are dispensed.

2. (2) A manufacturer may not:

   1. (a) directly or indirectly restrict or prohibit:

      1. (i) a pharmacy from contracting with a 340B covered entity, including by denying the pharmacy access to a drug that is manufactured by the manufacturer;
      2. (ii) a 340B covered entity from contracting with a pharmacy, including by denying the 340B covered entity access to a drug that is manufactured by the manufacturer;
      3. (iii) the acquisition, dispensing, or delivery of a 340B eligible drug to any location authorized by a 340B covered entity to receive the drug, unless prohibited by federal law; or
      4. (iv) a 340B covered entity from receiving a 340B eligible drug, including by imposing a time limitation on a 340B covered entity to replenish or submit a claim for a 340B eligible drug;

   2. (b) directly or indirectly:

      1. (i) require a 340B covered entity to purchase a 340B eligible drug from a supplier if the manufacturer would otherwise permit the 340B covered entity to purchase a drug that is not a 340B eligible drug from the supplier; or

      2. (ii) require a 340B covered entity or a contracted pharmacy to submit any claim data, utilization data, or information about a 340B covered entity's contracts with a third-party, unless the data or information sharing is required by federal law, as a condition for allowing:

         1. (A) the acquisition of a 340B eligible drug by a 340B covered entity; or
         2. (B) delivery of a 340B eligible drug to a 340B covered entity or a contracted pharmacy; or

   3. (c) interfere with:

      1. (i) a contract between a pharmacy and a 340B covered entity; or
      2. (ii) the ability of a pharmacy and a 340B covered entity to enter into a contract.
3. (3) The Public Employees' Benefit and Insurance Program created in Section 49-20-103 may adjust the program's business practices to mitigate any financial impacts resulting from this section.
4. (4) Nothing in this section is to be construed to conflict with federal law.

Amended by Chapter 22, 2026 General Session